Zenas BioPharma adopts 2026 Inducement Plan for up to 1M shares for new hires

Zenas BioPharma, Inc.

Plan reserves 1,000,000 shares of common stock for equity awards to new employees as hiring inducements.
Approved Dec 10, 2025 by Board; requires Compensation Committee or independent director approval per Nasdaq Rule 5635(c)(4).
Plan exempt from stockholder approval; grants include non-statutory stock options, SARs, RSUs, and restricted stock.
Eligible individuals are new hires or rehires after a bona fide break in employment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.